KirsnerJBInflammatory bowel disease. St. Louis, MO: Mosby Year Book, 1991; 37: 610–66.
2.
KanefMELakeAMBaylessTM. Decreased height velocity in children and adolescents before the diagnosis of Crohn's disease. Gastroeneterology1998; 95: 1084–88.
3.
GriffithsAMNguyenPSmithCGrowth and clinical course of children with Crohn's disease. Gut1993; 34: 939–43.
4.
MarkowiteJGrancherKRosaJGrowth failure in paediatric inflammatory bowel disease. Journal of Paediatrics Gastroenterology and nutrition1993; 16: 373–80.
5.
MotilAJGrandRJGrowth failure in children with inflammatory bowel disease: A prospective study. Gastro1993;105: 681–91.
6.
KirschnerB S. Growth and development in chronic inflammatory bowel disease. Acta-Paediatrica Scandinavice1990; 3665: 98–104.
7.
BurbridgeEJHuangSBaylessTM. Clinical manifestations of Crohn's disease in children and adolescents. Paediatrics1975; 55: 886.
8.
FarmerRGMichenerWM. Prognosis of Crohn's disease with onset in childhood or adolescence. Dig Dis Sci1979; 24: 752.
9.
McCafferyTONarrKSevere growth retardation in children with inflammatory bowel disease. Paediatrics1969; 45: 386.
10.
MotilKJGrandRJDavir-KraftE. The epidemiology of growth failure in children and adolescents with inflammatory bowel disease. Gastro1988; 95: 1523.
11.
MurchSHLamkinVASavageMOSerum concentrations of tum our necosis factor ∞in childhood chronic inflammatory bowel disease. Gut1991; 32: 913–17.
12.
BraeggerCPNicholsSMurchSHTumour necrosis factors ∞ in stool as marker of intestinal inflammation. Lancet1992; 339: 89–91.
13.
NeilsonOHBrynskorJBendtzenF. Circulating and mucosal concentrations of tumour necrosis factor and inhibitor(s) in chronic inflammatory bowel disease. Danish Med Bull1993; 40: 247–49.
14.
MurchSH. Inflammatory mediators and suppression of growth in paediatric chronic inflammatory bowel disease. InTytgartGNJ1995, Inflammatory Bowel Disease, pp 598–603Dordrecht, The Netherlands: Kluwer Academic Publishers.
15.
FilipssonSHultenLLindstedtG. Malabsorption of fat and vitamin B12 before and after intestinal resection for Crohn's disease. Scandinavian Journal of Gastroenterology1978; 13: 529–536.
16.
ChanATHFlemingCRO'FallonWMEstimated versus basal energy requirements in patients with Crohn's disease. Gastro1986; 91: 75–78.
17.
MailettPMurchS. Anorexia nervosa complicating inflammatory bowel disease. Archives of Disease in Childhood1990; 65: 298–300.
18.
De BenedettiFAlonziTMorettaAInterleukin 6 causes growth impairment in transgenic mice through a decrease in insulin like growth factor-1. A model for stunted growth in children with chronic inflammation. Journal of Clinical Invest1997; 99: 643–50.
19.
SeidmanELeleikoNAmentMNutritional issues in paediatric inflammatory bowel disease. Journal of Paediatric Gastroenterology and Nutrition1991; 23: 344A.
BellisRSeidmanEGBouthillierLChronic intermittent elemental diet improves growth failure in children with Crohn's disease. Gastro1988; 94: 603–610.
22.
AigesHMarkowiteJRosaJDunnF (1989). Home nocturnal nasogastric feedings in growth retarded adolescents with Crohn's disease. Gastro1989; 97: 905–910.
23.
BellisDCSeidmanEChronic intermittent elemental diet improves growth failure in children with Crohn's diseaseGastro1988; 94: 603.
24.
MotilKJAltchulerSIMineral balance during nutritional supplementation in adolescents with Crohn's disease and growth failureJournal of Paediatrics1985; 107: 473.
25.
SandersonIRUdeenSDaviesPSWRemission induced by an elemental diet in small bowel Crohn's disease. Archives of Disease in Childhood1987; 61: 123–27.
26.
BeattieRMSchifffinEJSPolymeric nutrition as the primaiy therapy of acute Crohn's disease. Alimentary Pharmacology and Therapeutics1994; 8: 609–615.
27.
O'MorainCSegalAWLeviAJ. Elemental diet as primary treatmenl of acute Crohn's disease. Br Med J1984; 288: 1859–62.
28.
SeidmanEGBoutillierLElemental diet versus prednisone as primary treatment of Crohn's disease. Gastro1986; 90A1625.
29.
SaverymattuSHodgsonMFControlled trial comparing prednisolone with elemental diet plus non-absorbable antibodies in active Crohn's disease. Gut1985; 26: 994–98.
30.
HuntJBPayne-JonerJJA randomised controlled trial of elemental diet and prednisolone as primary therapy in acute exacerbations of Crohn's disease.
31.
GorardDAHuntJBEarly response and subsequent relapse rates in Crohn's disease treated with elemental diet or prednisolone. Gastrc1991; 100: A213.
32.
SeidtnanEJonerARelapse prevention/growth enhancement in paediatric Crohn's disease; multicentre randomised controlled trial of intermittent enteral nutrition versus alternate day prednisone. Journal of paediatric Gastro & Nutrition1996; 23: 344A.
33.
GiorginiSLStephensRVThayerWR. The use of medical bypass in the therapy of Crohn's disease. American Journal of Digestive Disease1973; 18: 153–57.
34.
ShorterRGHuizengaKASpencerRJ. A working hypothesis for the aetiology and pathogenesis of non-specific inflammatory bowel disease. Digestive Diseases1977; 17: 1024–1032.
35.
WardM. The pathogenesis of Crohn's disease. Lancet1977; ii: 903–905.
36.
LeviAJ. Diet in the management of Crohn's disease. Gut1985; 26: 985–88.
37.
LoganRFAGillonJFerringtonCFergusonA. Reduction in intestinal protein loss by elemental diet in Crohn's disease of the small bowel. Gut1981; 22: 383–87.
38.
ArnottIDRGhoshSImprovement in whole gut lavage fluid inflammatory markers in patients with Crohn's disease treated with elemental diet. Gut1997; supplement 3: A225.
39.
BreeseEJMichieCATumour necrosis factor ac producing cells in the intestinal mucosa of children with inflammatory bowel disease. Gastro1994. 106: 1455–66.
40.
BreeseEJNmichieCAThe effect of treatment of lymphokine-secreting cells in the intestinal mucosa of children with Crohn's disease. Alimentary Pharmacology and Therapeutics1995; 9: 547–53.
41.
FellJMEHollisAKitchingPResolution of mucosal inflammation and fall in interleukin-1 beta mRNA in active Crohn's disease in response to polymeric diet CT3 211. Journal of Paediatric Gastro & Nutrition1997; 24: 474.
42.
O'MorainCSegalAWLeviAJ. Elemental diet as primary treatment of acute Crohn's disease. BMJ1984; 288: 1859–1862.
43.
RoyallDKahanIBakerJPClinical and nutritional outcome of an elemental versus semi-elemental diet in active. Crohn's disease. Gastro1992; 102: A576.
44.
ItoKHiwatashiNImprovement of abnormal intestinal permeability in active Crohn's disease by an elemental diet.
45.
LochsHSteinhardtHJComparison of enteral nutrition and drug treatment in active Crohn's disease. Gastro1991; 101: 881–88.
46.
GiafferMHNorthGHoldsworthCD. Controlled trial of polymeric versus elemental diet in treatment of active Crohn's disease. Lancet1990; 335: 816–19.
47.
MorrowWJWHomsyJSwansonCEDietary fat influences the expression of auto-immune disease in MLR I pr/1 pr miceImmunology1986; 59: 439–43.
48.
SchremerGFFlyeWBruntEEssential fatty acid depletion of renal allografts and prevention of rejection. Science1988; 240: 1032–33.
49.
DenkoCW. Modification of adjuvant inflammation in rates deficient in essential fatty acids. Agents Actions1976; 65: 636–41.
50.
StrasserTFischerSWeberPC. Leukotriene BS in formed in human neutrophils after dietary supplementation with, eicosapentaenoci acid. Proc Natl Acad Sci USA1985; 82: 1540–43.
51.
LeeTHHooverRLEffect of dietary enrichment with eicosapentaenoci and docosachexaenoic acids on in vitro neutrophil and monocyte leukotriene generation and neutrophil formation. N EngI J Med1985; B 12: 1217–24.
52.
EndersSGhorbaniPTKellyVEThe effect of dietary supplementation with n-3 polyunsaturated fatty acids on the - synthesis of interleukin-1 and tumour necrosis factor by mononuclear cells. N EngI J Med1989; 320: 265–71.